Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
Submitted by
admin
on February 9, 2016 - 5:35pm
Source:
Fierce Biotech
News Tags:
FDA
advisory panels
Pfizer
Celltrion
Remicade
JNJ
biosimilars
Headline:
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
Do Not Allow Advertisers to Use My Personal information
